Teton Advisors Inc. Trims Stock Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Teton Advisors Inc. decreased its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 25.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,000 shares of the medical instruments supplier’s stock after selling 1,000 shares during the period. Teton Advisors Inc. owned approximately 0.06% of Mesa Laboratories worth $314,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MLAB. SG Americas Securities LLC lifted its stake in Mesa Laboratories by 23.1% in the 3rd quarter. SG Americas Securities LLC now owns 2,928 shares of the medical instruments supplier’s stock valued at $308,000 after buying an additional 549 shares in the last quarter. Raymond James & Associates grew its stake in Mesa Laboratories by 3.0% in the third quarter. Raymond James & Associates now owns 67,426 shares of the medical instruments supplier’s stock worth $7,084,000 after purchasing an additional 1,984 shares in the last quarter. Bahl & Gaynor Inc. lifted its holdings in Mesa Laboratories by 76.0% in the third quarter. Bahl & Gaynor Inc. now owns 9,035 shares of the medical instruments supplier’s stock worth $949,000 after acquiring an additional 3,902 shares during the last quarter. Illinois Municipal Retirement Fund bought a new position in Mesa Laboratories in the third quarter worth about $341,000. Finally, Seizert Capital Partners LLC bought a new position in Mesa Laboratories in the third quarter worth about $1,347,000. Institutional investors and hedge funds own 90.60% of the company’s stock.

Mesa Laboratories Trading Up 2.9 %

MLAB stock traded up $3.19 during midday trading on Thursday, reaching $113.37. The company’s stock had a trading volume of 39,512 shares, compared to its average volume of 47,367. Mesa Laboratories, Inc. has a 52 week low of $82.86 and a 52 week high of $172.80. The stock has a market cap of $611.06 million, a PE ratio of 648.16 and a beta of 0.82. The company has a quick ratio of 1.86, a current ratio of 2.68 and a debt-to-equity ratio of 0.58. The business’s 50-day simple moving average is $105.29 and its 200-day simple moving average is $99.74.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings data on Monday, February 5th. The medical instruments supplier reported $1.46 EPS for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.01). Mesa Laboratories had a return on equity of 7.41% and a net margin of 0.45%. The company had revenue of $53.47 million for the quarter, compared to analyst estimates of $54.90 million. As a group, sell-side analysts expect that Mesa Laboratories, Inc. will post 6.15 EPS for the current year.

Mesa Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Friday, May 31st will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 0.56%. The ex-dividend date is Friday, May 31st. Mesa Laboratories’s payout ratio is 376.49%.

Wall Street Analysts Forecast Growth

Separately, Evercore ISI raised their price objective on shares of Mesa Laboratories from $124.00 to $130.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions.